FDA Awards UC $2.7 Million Grant The News Record The study aims to end questions concerning the differences between generic and brand-name versions of tacrolimus, common immunosuppressive drugs, used to help post-transplant patients accept their new organs. “The public concern [with tacrolimus] is ... |
